News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
Discover Latest #Rial News, Articles and Videos with Contenting
The following are news articles, blog posts, and videos related to Rial. You can explore them further for more information on the currency, its value, and its role in the global economy. News 1. Iran's Currency Reaches Record Low Against US Dollar In August 2018, Iran's currency, the rial, hit an all-time low against the US dollar. On August 8th, one US dollar was worth about 110,000 rials, making it more difficult for Iranian citizens to purchase goods and services. The drop in the value of the rial has been attributed to the upcoming sanctions from the US, as well as the country's economic mismanagement. 2. Iran Introduces New Currency In April 2019, the Iranian government announced that it would be introducing a new currency, the toman. The toman is equal to 10,000 rials, and was intended to reduce confusion and make transactions easier. The move was also seen as an attempt to boost the value of the rial, although it remains to be seen if this measure will be successful. Blog Posts 1. The Impact of US Sanctions on the Iranian Rial In this
Big Lots conducts going-out-of-business sales after sale of company falls through
Discount chain Big Lots is conducting going-out-of-business sales at its remaining locations after a sale of the company didn't materialize. The Columbus, Ohio-based retailer, which sells furniture, home decor and other items, filed for Chapter 11 bankruptcy protection in early September and said private equity firm Nexus Capital Management LP had agreed to acquire “substantially all of the company’s assets.” Big Lots said its goal would be to complete a sale by early January.
Dow Soars as Market Passes Final Inflation Test of 2024
The stock market on Friday put a dent in its steep slide from earlier this week, after the last major inflation test of the year came in cooler than expected. The Dow Jones Industrial Average gained 499 points, or 1.2%. The S&P 500 was up 1.1%. The Nasdaq Composite climbed up 1%. Stocks actually op
55th GST Council Meeting: No GST payable on penal charges levied & collected by banks & NBFCs from borrowers for non-compliance, says Nirmala Sitharaman | Zee Business
The GST Council has made a host of decisions concerning a variety of areas including certain snacks, electric vehicles (EVs) and construction materials. Finance and Corporate Affairs Minister Nirmala Sitharaman chaired the 55th meeting of the GST Council in Jaisalmer, Rajasthan. Here are some of the key takeaways from the 55th meeting of the GST Council. Get more GST News and Business News on Zee Business.
Tesla Recalls Nearly 700,000 Vehicles Over Tire Pressure Monitoring System Issue - ForexTV
Tesla Inc. (TSLA) has announced a recall affecting approximately 700,000 vehicles due to an issue with the tire pressure monitoring light.The recall targets specific models, including the 2024 Cybertruck, the 2017-2025 Model 3, and the 2020-2025 Model Y. The problem lies with the tire pressure monitoring system (TPMS) warning light, which may fail to stay illuminated between driving cycles, thereby not alerting the driver to low tire pressure.This issue results in non-compliance with Federal Motor Vehicle Safety Standard number 138, concerning "Tire Pressure Monitoring Systems."To address the issue, Tesla has provided a complimentary over-the-air software update. Owners can expect to receive notification letters by mail on February 15, 2025.This recall is not an isolated incident for Tesla. Reports indicate that the Cybertruck has already been subject to seven recalls this year alone. Notably, in October, Tesla recalled around 27,000 Cybertrucks due to a rearview camera defect that could heighten accident risk. Similarly, in July, the company recalled approximately 1.85 million vehicles due to a software glitch that could fail to detect an unlatched hood.The material has been provided by InstaForex Company - www.instaforex.com
Vertex' Trikafta Gets Expanded FDA Approval For Cystic Fibrosis Treatment - ForexTV
Vertex Pharmaceuticals (VRTX) announced on Friday that the U.S. Food and Drug Administration (FDA) has broadened its approval of a cystic fibrosis medication to include additional patients with varying mutation types of the disease.The FDA has sanctioned the extended use of Trikafta for cystic fibrosis (CF) patients aged 2 and above. Those eligible must possess at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, or a mutation that demonstrates a positive response to Trikafta according to clinical or laboratory data.Notably, the safety profile regarding liver injury and liver failure has been updated from general warnings and precautions to a more serious boxed warning. Following this approval, 94 new non-F508del CFTR mutations have been included on the Trikafta label, thereby allowing approximately 300 more CF patients in the U.S. access to a treatment targeting the root cause of their condition for the first time.Initially authorized in 2019, Trikafta has been a significant treatment option for tens of thousands of individuals with cystic fibrosis, as noted by Vertex's Chief Medical Officer, Dr. Carmen Bozic."Since its initial approval in 2019, TRIKAFTA has profoundly impacted the lives of countless individuals with cystic fibrosis," commented Dr. Carmen Bozic, Executive Vice President of Global Medicines Development and Medical Affairs, and Chief Medical Officer of Vertex. "With this latest approval, even more patients can now benefit from a treatment that addresses the root cause of their illness. We are committed to advancing efforts to expand the availability of our therapies to patients globally."The material has been provided by InstaForex Company - www.instaforex.com
Vertex's Cystic Fibrosis Drug Alyftrek Gets FDA Approval - ForexTV
Vertex Pharmaceuticals Inc. (VRTX) announced on Friday that the U.S. Food and Drug Administration (FDA) has approved Alyftrek for the treatment of cystic fibrosis.Alyftrek is a cutting-edge, once-daily triple combination drug that modulates the cystic fibrosis transmembrane conductance regulator (CFTR) for patients aged six and older. It is specifically designed for individuals with at least one F508del mutation or other CFTR gene mutations that respond to Alyftrek."This approval marks our fifth CFTR modulator to receive FDA approval, representing a major milestone in our ongoing quest to bring innovative treatments to those with cystic fibrosis," stated Reshma Kewalramani, M.D., CEO and President of Vertex. "For over two decades, we have been committed to addressing the root cause of cystic fibrosis, expanding treatment options, and enhancing CFTR function for sufferers. Alyftrek, with its convenient once-daily dosing, efficacy across 31 additional mutations, and superior reductions in sweat chloride levels compared to TRIKAFTA, advances us further towards this goal."The approval is based on data from the most comprehensive Phase 3 program ever conducted for cystic fibrosis, involving over 1,000 patients from more than 20 countries and 200 sites."In Phase 3 trials, across diverse genotypes, once-daily Alyftrek demonstrated non-inferiority in ppFEV1 response and a statistically significant improvement in sweat chloride levels compared to TRIKAFTA," noted Dr. Claire L. Keating, Co-Director of the Gunnar Esiason Adult Cystic Fibrosis and Lung Program at Columbia University and a key investigator in the Alyftrek clinical trials. "Alyftrek offers promising potential for enhancing patient care."Alyftrek is also being reviewed by health authorities in the European Union, the United Kingdom, Canada, Switzerland, Australia, and New Zealand for potential approval.The material has been provided by InstaForex Company - www.instaforex.com
EHang And Chongqing Changan Automobile Partner On Flying Car Innovations - ForexTV
EHang Holdings Limited (EH), a prominent Urban Air Mobility technology platform company, announced on Saturday that it has entered into a strategic cooperation agreement with Chongqing Changan Automobile Co., Ltd., a leading Chinese automotive manufacturer. The partnership will focus on joint efforts in research and development, manufacturing, sales, and operational activities related to flying-car technologies. This includes the creation of electric vertical takeoff and landing (eVTOL) aircraft and pioneering flying car models.Under the terms of this agreement, both companies will combine their respective strengths and resources to advance the development of next-generation flying vehicles. These vehicles will feature cutting-edge technology, innovative design with a forward-thinking approach, and market-ready competitiveness.The material has been provided by InstaForex Company - www.instaforex.com